Instead of mimicking GLP-1, it stimulates your body to produce its own GLP-1 naturally
Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D (2022) Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Step 3: Inject on the new day
As more employers bring SmartRx to their people, we expect the impact to scale significantly by reducing drug costs and building the clinical foundation that makes savings and outcomes stick
Remove the trigger, and hair regrows
Understanding potential errors in patch application is essential for optimising therapeutic outcomes and minimising adverse effects